Friday, 15 Feb 2019

You are here

Dr. Olga Petryna - Canakinumab in CVD Pts Prevents Acute Gout Attacks

Dr. Petryna reviews Dr. Dan Solomon's EULAR 2018 plenary presentation showing a 50-60% reduction in acute gout amongst CVD patients treated with canakinumab.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

The RheumNow Week in Review – 6 January...

06 Jan 2017

ACR/AAHKS Guidelines on Perioperative...

21 Jun 2017

Dr. Tajvur Saber: Why RheumNow is...

14 Nov 2016

Dr. Cassie Calabrese: RA Paradigm...

17 Jul 2017

Dr. Jack Cush at EULAR 2018: The Art of...

14 Jun 2018

Dr. Janet Pope: Interstitial Lung...

08 Nov 2017

EULAR 2016 Round-Up - Dr. Jack Cush

19 Jun 2016

Dr. Kathryn Dao: Lupus SynBiose Study...

21 Nov 2017

RheumNow Week in Review – 2 September...

02 Sep 2016

Dr. Rachel T. Huston: Cardiovascular...

08 Dec 2016

Dr. Jeffrey Chwa: A "Large"...

09 Feb 2018

QD Video - Non-Traumatic Hemarthrosis

18 Jan 2019